Motavizumab (RSV) Antibody, Monoclonal
Code | Size | Price |
---|
PSI-10-089-0.1mg | 0.1mg | £657.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: IgG1-kappa
Antibody Clonality: Recombinant Antibody
Regulatory Status: RUO
Shipping:
blue ice
Storage:
Store at -80˚C
Images
Documents
Further Information
Additional Names:
MEDI-524, RSV[Respiratory syncytial virus], RSV[Respiratory syncytial virus]
Background:
Motavizumab is a second generation,ultra-potent, affinity-matured,humanized mAb derived from palivizumab that reduces replication of Respiratory Syncytial Virus (RSV),a pathogen which causes lower respiratory tract disease.
Buffer:
PBS buffer pH7.5
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Humanized / RSV [Respiratory syncytial virus]
Purification:
>95%
Research Area:
Drug Analogues
Source:
CHO cells
User NOte:
Optimal dilutions for each application to be determined by the researcher.